Summary of clinical results
DEXERYL
Evaluation of the cutaneous tolerance and efficacy of a Dexeclear Blemish Foaming gel used under normal conditions during 4 weeks by 40 adults and adolescents. Use test under dermatological conditions.
Objective
To assess the dermatological tolerance of the product on the face, thorax, and upper back
To assess the objective and subjective efficacy and to assess the cosmetic acceptability
Population
43 adolescents (49%) and adults (51%) subjects, between 12 and 35 years old, mean age: 21 years old, phototype III to VI with facial and back acne.
- Face skin type: combination, oily
- Body skin type (back and thorax): oily
- IGA score = 2 (79%) to 3 (21%), with 10 to 30 non-inflammatory lesions and 5 to 10 inflammatory lesions.
Design ( application)
Applied once to twice daily on the face and body, for 28 days
Evaluation criteria
- Tolerance: dermatological assessments through physical and functional signs
- Clinical efficacy: Evaluationby a dermatologist (assessment of acne severity (IGA)
- Evaluation of the product efficacy in inflammatory and non-inflammatory acne vulgaris: by counting lesions
- Self-assessment efficacy: evaluation through self-Assessment questionnaires
Results
- Very good cutaneous tolerance
- At day 28, statistically significant decrease of non-inflammatory lesions (Global): -18%, for 93% of subjects (adults and adolescents)
- 100% of teenagers perceive an efficacy on pimples within 15 days
Conclusion
- Very good tolerance.
- - 18% of non-inflammatory lesions (adults and adolescents) after 28 days.
- 100% of teenagers perceived an efficacy on pimples within 15 days
More summaries of clinical results
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.